FDA Import Refusal BNI-0064336-9/271/4 — Beltapharm SPA
The FDA refused shipment BNI-0064336-9/271/4 from Beltapharm SPA (Italy) on April 20, 2018. The refused product falls under Drugs and Biologics — CLOBETASOL PROPIONATE (GLUCOCORTICOID). Cited charges: 118,3280,483,75,82 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 20, 2018
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 64LCJ67 CLOBETASOL PROPIONATE (GLUCOCORTICOID)
- Charges
- 118,3280,483,75,82